Tuesday, May 05, 2009

When a killer pandemic hits, the burning question is: who gets treatment as a priority because everyone is affected

Perhaps one should be buying shares in pharmaceutical companies such as Roche or GlaxoSmithKline which produce the two principal antivirals Tamiflu and Reflenza.

40-odd years ago when I was working at a mining house, a director asked me to devise an investment strategy in case of nuclear war.

Two minutes of reflection gave the answer: Lay down a case of vintage Bordeaux wine, a dozen cork screws and a dozen claret glasses. Nuclear war would destroy the world as we knew it — the 12 board members might just as well die with a decent glass of wine in their hands. And if Armageddon didn’t arrive, they could always enjoy the wine with lunch.

SHOOT: Good article this.
clipped from www.thetimes.co.za

We have been there before, when avian flu from China and Vietnam sent the world into a panic in 2005. However, this time things seem different. Avian flu was deadly to any bird affected by it, and it was transmitted to humans in close contact with birds — a fairly small percentage of the world population.

The current virus that has originated in Mexico is a mutation of the 2005 avian variety. It uses pigs only as its breeding ground and is transmitted by humans to humans . Its potential to reach pandemic proportions is, therefore, that much greater.

At this stage, a pandemic is nowhere near certain. But this flu’s possible economic impact could be far worse than that feared back in 2005.

Then, the world economy was soaring and a pandemic was likely only to have reined in economic growth. A pandemic now could bring a complete halt to an early recovery from the current recession.

 blog it

No comments: